The effect of testosterone replacement treatment on immunological featuresof patients with Klinefelter's syndrome

Citation
Ih. Kocar et al., The effect of testosterone replacement treatment on immunological featuresof patients with Klinefelter's syndrome, CLIN EXP IM, 121(3), 2000, pp. 448-452
Citations number
44
Categorie Soggetti
Immunology
Journal title
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
ISSN journal
00099104 → ACNP
Volume
121
Issue
3
Year of publication
2000
Pages
448 - 452
Database
ISI
SICI code
0009-9104(200009)121:3<448:TEOTRT>2.0.ZU;2-L
Abstract
Although the effects of androgen deficiency in the immune system have long been appreciated, little is known about the immunological features of patie nts with Klinefelter's syndrome (KS). On the other hand, interest in androg ens as a possible treatment for some autoimmune diseases is growing. In the present study, some immunological parameters were evaluated in 26 patients with KS prior to androgen replacement treatment (ART) and the results were compared with those in 19 healthy control subjects. Patients were then tre ated with testosterone for 6 months and the pre- and post-treatment finding s were compared. Serum levels of IgG, IgA, IgM, C3c and C4 were measured by nephelometry and lymphocyte subsets and CD4(+)/CD8(+) ratios were examined by flow cytometry. IL-2 and IL-4 levels were measured by ELISA. Pretreatme nt levels of the serum IgA, IgG, IgM, IL-2 and IL-4 of the patients were hi gher than those of the controls and were all decreased significantly follow ing ART. The pretreatment absolute numbers and percentages of CD3(+), CD4(), CD19(+) cells and CD4(+)/CD8(+) ratios of patients with KS were higher t han those of the controls and were all decreased with ART. Percentages of C D8(+) cells were increased significantly, while C3 and C4 levels were both significantly decreased after ART. It is concluded that the lack of testost erone in patients with KS enhances cellular and humoral immunity and that A RT may suppress this.